
Bausch Health Companies BHC
€ 5.64
5.56%
Bausch Health Companies DPO | BHC
DPO Jährlich Bausch Health Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 78.1 | 63.8 | 52.3 | 45.3 | 61.2 | 64.4 | 62.6 | 79.9 | 79.2 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 79.9 | 45.3 | 65.2 |
DPO anderer Aktien in der Arzneimittelhersteller
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
212 | $ 3.26 | 0.62 % | $ 1.25 B | ||
|
China Pharma Holdings
CPHI
|
47.6 | $ 0.82 | 0.1 % | $ 3.52 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B | ||
|
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
889 | $ 6.79 | 0.59 % | $ 101 M | ||
|
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
4.75 K | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M | ||
|
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | ||
|
Evolus
EOLS
|
59.4 | $ 9.3 | 2.76 % | $ 600 M | ||
|
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | ||
|
Assertio Holdings
ASRT
|
122 | - | - | $ 150 M | ||
|
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
109 | - | - | $ 1.08 B | ||
|
Harrow Health
HROW
|
199 | $ 38.54 | 0.73 % | $ 1.42 B | ||
|
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | ||
|
Emergent BioSolutions
EBS
|
65.2 | $ 6.21 | 0.08 % | $ 332 M | ||
|
Rockwell Medical
RMTI
|
15.4 | $ 7.99 | 1.31 % | $ 287 M | ||
|
Organogenesis Holdings
ORGO
|
94 | $ 1.71 | 4.27 % | $ 217 M | ||
|
Perrigo Company plc
PRGO
|
64.2 | $ 14.92 | 4.56 % | $ 2.07 B | ||
|
Tilray
TLRY
|
66.9 | $ 4.5 | 0.22 % | $ 4.01 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
43.3 | $ 1.33 | 0.38 % | $ 2.24 M | ||
|
SCYNEXIS
SCYX
|
20.2 | $ 5.3 | 0.47 % | $ 265 M | ||
|
Veru
VERU
|
251 | $ 2.64 | 0.94 % | $ 38.7 M | ||
|
Viatris
VTRS
|
70.9 | $ 16.88 | 0.03 % | $ 19.4 B | ||
|
TherapeuticsMD
TXMD
|
723 | $ 2.21 | 0.22 % | $ 25.6 M | ||
|
cbdMD
YCBD
|
68.6 | $ 0.5 | 4.68 % | $ 2.01 M | ||
|
Canopy Growth Corporation
CGC
|
51.7 | $ 0.97 | 0.17 % | $ 289 M | ||
|
ProPhase Labs
PRPH
|
845 | - | - | $ 5.07 M | ||
|
Aurora Cannabis
ACB
|
-807 | $ 3.95 | 1.54 % | $ 217 M |